Please login to the form below
National Cancer Institute
This page shows the latest National Cancer Institute news and features for those working in and with pharma, biotech and healthcare.
FDA will maintain the pace, vows Woodcock, but warns of skills gap
His successor, Ned Sharpless has been drafted in from his former role as head of the National Cancer Institute (NCI), but remains for now an interim Commissioner, and one certainly less
Latest news
-
Iovance up on good ASCO abstract data for cervical cancer therapy
big gainer was Iovance Biotherapeutics which climbed on data for its cancer immunotherapies. ... Iovance’s approach to immunotherapy was pioneered by Steven Rosenberg of the US National Cancer Institute (NCI).
-
Bluebird’s myeloma CAR-T safety ‘could support outpatient use’
responses with a manageable safety profile we’ve seen for bb2121 to date,” said the trial’s principal investigator James Kochenderfer of the US National Cancer Institute (NCI).
-
Gottlieb signs off with flair – and pledge of further drug price commentary
He now hands over to interim FDA commissioner Ned Sharpless, formerly head of the National Cancer Institute (NCI), but ended his final days in the post with a redoubled focus on
-
Second chance for AstraZeneca’s selumetinib with breakthrough designation
The news is a welcome turn around for the molecule, which failed in a phase 3 trial in non-small cell lung cancer (NSCLC) back in 2016. ... These results were presented by the National Cancer Institute (NCI) at last year’s ASCO congress, and the drug
-
Gottlieb admonishes industry for clinical trial failings
Gottlieb – who is leaving the FDA next month and will be replaced on an interim basis by National Cancer Institute (NCI) director Ned Sharpless – says that the advent in precision medicine, ... study of neoadjuvant and personalised drugs for breast
More from news
Approximately 1 fully matching, plus 84 partially matching documents found.
Latest Intelligence
-
30 Women Leaders in UK Healthcare (part 3)
As Director of the MRC Clinical Trials Unit she has led the National Cancer Research Network in applying clinical trials for the improvement of cancer management in the UK. ... She now sits in the House of Lords as an independent peer, and is chair of
-
An effective commercial model for cancer care
Treatments for cancer are among the most expensive of all, regardless of disease. ... In an online survey of 8, 411 cancer patients administered by LIVESTRONG (the Lance Armstrong Foundation) and the National Cancer Institute's Health Information
-
EATRIS and the new age of partnering
In a display of its global ambition, EATRIS is joining with Cancer Research UK to bring representatives of the US's National Cancer Institute to a workshop in Brussels in October ... In October the National Cancer Institute will meet with specialists -
-
Diagnostics are rising up the pharma value chain
According to the US National Cancer Institute, about 12 per cent of women in the general population will develop breast cancer sometime during their lives. ... lung cancer, which was backed together with Roche Diagnostics' cobas EGFR Mutation Test.
-
Country report: The healthcare market in France
National Cancer Institute (NCI) or the National Institute for Prevention and Education for Health (NIPEH). ... This applies to oncology drugs under France's national cancer care plan that includes fast access to new therapies.
More from intelligence
Approximately 0 fully matching, plus 5 partially matching documents found.
Latest appointments
-
Cancer Research UK's Karen Vousden to join BMS board
She has more than 30 years experience in cancer research and her previous roles have included director of the Beatson Institute for Cancer Research and leadership positions at the US National ... Cancer Institute.
-
AZ and Medimmune bolsters immuno-oncology leadership
roles at the National Cancer Institute (NCI). ... Institut Gustave Roussy - a leading cancer-research institute.
-
Iris Pauporté joins OSE Immunotherapeutics
Pauporté will lead the clinical development of the firm's lung cancer candidate Tedopi, which is currently in phase III trials, and will be responsible for exploring the drug's potential ... She brings over 20 years of biomedical and clinical research
-
AstraZeneca appoints Sean Bohen as chief medical officer
Before joining Genentech he was a clinical instructor in oncology at Stanford University School of Medicine, a research associate at the Howard Hughes Medical Institute and a postdoctoral fellow at the ... National Cancer Institute.
-
JPA adds to Washington team
He also managed public health communications programmes for the Food and Drug Administration and National Cancer Institute.
More from appointments
Approximately 0 fully matching, plus 8 partially matching documents found.
Latest from PMHub
-
Parachuting Behind Enemy Lines: OncoSec’s Attack on Visceral Tumors via Its New Visceral Lesion Applicator (VLA)
References. National Cancer Institute. Surveillance, Epidemiology, and End Results Program. Cancer stat facts: Liver and intrahepatic bile duct cancer. ... 2018; 15(10):599-616. National Cancer Institute. Surveillance, Epidemiology, and End Results
-
World AIDS Day 2018: Fighting the stigma surrounding HIV
HIV infection. Nat Rev Dis Primers. 2015; 1: 15035. National Cancer Institute. ... HIV infection and cancer risk. Available at: . Accessed November 2018. UCSF Health. AIDS diagnosis. Available at: . Accessed November 2018. Avert. Symptoms and stages of
-
Mastering the precision medicine opportunity
The National Cancer Institute and the Centre for Disease Control both use the 4Ps model to define precision medicine, considering it a form of evidence-based medicine that is:. ... Parallel to the increasing number of testing options is the evolving
-
ASCO 2015: What you missed in Chicago
Specifically, we thought the checkpoint inhibitors in head and neck, lung cancer and melanoma really shone. ... The second area that really impressed me was the large National Cancer Institute (NCI) trial[3] that will look to treat patients with solid
More from PMHub
Approximately 0 fully matching, plus 4 partially matching documents found.
Featured jobs
- Senior Account Executive – Account Manager – Healthcare Advertis...
-
£32000 - £43000 Bonus Benfits
- Senior Medical Writer, Healthcare Advertising Agency
-
£45, 000 – £50, 000
- Account Director, Healthcare Communications
-
Salary TBC
-
Account Director – UK Office
-
Excellent salary and benefits
- FREELANCE Account Director – Healthcare Advertising – London – 3...
-
Competitive Daily Rates
Subscribe to our email news alerts
- AZ, Merck’s Lynparza scores market-expanding clinical success
- Moving annual total (MAT)
- GSK hires Merck KGaA exec to lead US pharma business
- Roche undercuts price of Bayer cancer drug after winning FDA approval
- Leaked no-deal Brexit document forecasts widespread shortages
- Novartis chooses internal replacement for US pharma president role
- Empowered patients: shaking the foundations of healthcare
- Roche’s Hemlibra scores broader NHS funding
- AZ’s Imfinzi combo bombs again in non-small cell lung cancer
- NICE’s fast-track catapults Skyrizi into market
- GSK files anaemia drug daprodustat in Japan, its first market
- A uniquely English genomic medicine service
PMHub
Publicis Resolute
Publicis Resolute provides real-life practical solutions to your issues, without fuss or fluff. We are an experienced team with a...
Latest intelligence
- Empowered patients: shaking the foundations of healthcare
- Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
- A uniquely English genomic medicine service
- The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
- Blended Intelligence
- Data is the most valued commodity of the modern world. For P&P it's all about the application....
Quick links
Infographics
